Seelige R, Searles S, Bui J
Cell Mol Life Sci. 2017; 75(2):225-240.
PMID: 28744671
PMC: 11105730.
DOI: 10.1007/s00018-017-2597-7.
Nathan C
Mol Med. 2013; 19(1):305-13.
PMID: 24089245
PMC: 3789094.
DOI: 10.2119/molmed.2013.00063.
Nathan C, Cunningham-Bussel A
Nat Rev Immunol. 2013; 13(5):349-61.
PMID: 23618831
PMC: 4250048.
DOI: 10.1038/nri3423.
Liu X, Zheng X, Wang N, Cao H, Lu Y, Long Y
Br J Pharmacol. 2010; 162(6):1274-90.
PMID: 21108626
PMC: 3058161.
DOI: 10.1111/j.1476-5381.2010.01114.x.
Sone S, Tsuruo T, Sato S, Yano S, Nishioka Y, Shinohara T
Jpn J Cancer Res. 1996; 87(7):757-64.
PMID: 8698627
PMC: 5921165.
DOI: 10.1111/j.1349-7006.1996.tb00289.x.
Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration.
Granger D, Taintor R, Cook J, Hibbs Jr J
J Clin Invest. 1980; 65(2):357-70.
PMID: 7356685
PMC: 371374.
DOI: 10.1172/JCI109679.
Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.
Swinburne S, Moore M, Cole P
Br J Cancer. 1982; 46(4):625-34.
PMID: 7138768
PMC: 2011179.
DOI: 10.1038/bjc.1982.247.
Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. I. 2-Mercaptoethanol-induced stimulation of the uptake of cystine, an essential amino acid.
Ohmori H, Yamamoto I
J Exp Med. 1982; 155(5):1277-90.
PMID: 7040590
PMC: 2186673.
DOI: 10.1084/jem.155.5.1277.
Macrophage activation by tuftsin and muramyl-dipeptide.
Florentin I, MATHE G
Mol Cell Biochem. 1981; 41:113-8.
PMID: 6895772
DOI: 10.1007/BF00225301.
Augmentation of spontaneous macrophage-mediated cytolysis by eosinophil peroxidase.
Nathan C, Klebanoff S
J Exp Med. 1982; 155(5):1291-308.
PMID: 6802924
PMC: 2186678.
DOI: 10.1084/jem.155.5.1291.
I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.
Nelson M, Nelson D, Hopper K
Am J Pathol. 1981; 104(2):114-24.
PMID: 6789682
PMC: 1903754.
The human tumor cloning assay in cancer drug development. A review.
Agre P, Williams T
Invest New Drugs. 1983; 1(1):33-45.
PMID: 6381376
DOI: 10.1007/BF00180190.
Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.
Sheid B, Boyce J
Cancer Immunol Immunother. 1984; 17(3):190-4.
PMID: 6332671
PMC: 11039279.
DOI: 10.1007/BF00205484.
Induction of cystine transport activity in mouse peritoneal macrophages.
Watanabe H, Bannai S
J Exp Med. 1987; 165(3):628-40.
PMID: 2880923
PMC: 2188288.
DOI: 10.1084/jem.165.3.628.
Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering.
Nathan C, Root R
J Exp Med. 1977; 146(6):1648-62.
PMID: 925614
PMC: 2181906.
DOI: 10.1084/jem.146.6.1648.
Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leucocytes.
Giovarelli M, Comoglio P, Forni G
Br J Cancer. 1976; 34(3):233-8.
PMID: 788762
PMC: 2025188.
DOI: 10.1038/bjc.1976.157.
Macrophage-mediated natrual cytotoxicity against various target cells in vitro. I. Macrophages from diverse anatomical sites and different strains of rats and mice.
Keller R
Br J Cancer. 1978; 37(5):732-41.
PMID: 656302
PMC: 2009628.
DOI: 10.1038/bjc.1978.111.
Growth enhancing property of human monocytes from normal donors and cancer patients.
Trejdosiewicz L, Trejdosiewicz A, LING N, Dykes P
Immunology. 1979; 37(1):247-52.
PMID: 468301
PMC: 1457289.
Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi.
Nathan C, Nogueira N, Juangbhanich C, Ellis J, Cohn Z
J Exp Med. 1979; 149(5):1056-68.
PMID: 376774
PMC: 2184875.
DOI: 10.1084/jem.149.5.1056.
Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.
Nathan C, Brukner L, Silverstein S, COHN Z
J Exp Med. 1979; 149(1):84-99.
PMID: 368287
PMC: 2184749.
DOI: 10.1084/jem.149.1.84.